SCHEMBL20847685

SCHEMBL20847685

CCc1ccc(-c2ccc(C(=O)O)c(F)c2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 4/20 0.68
RARA P10276 2/20 0.68
RARG P13631 1/20 0.68
RAB9A P51151 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
MCL1 Q07820 1/20 0.50
BCL2 P10415 1/20 0.49
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
ALDH1A1 P00352 1/20 0.48
XDH P47989 1/20 0.47
SLC22A12 Q96S37 1/20 0.47
CA12 O43570 1/20 0.45
ALPL P05186 1/20 0.45
CA9 Q16790 1/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ADRB1 P08588 1/20 0.44
ADRB3 P13945 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7736771 0.87 RARB (0.78) RARBRARARARGMCL1ALDH1A1
SCHEMBL669282 0.85 RARB (0.54) RARBRARARARGRAB9ASMN1; SMN2
SCHEMBL30641680 0.85 RARB (0.60) RARBRARARARGMCL1RXRA
SCHEMBL16534058 0.85 RARB (0.60) RARBRARARARGMCL1RXRA
SCHEMBL20556331 0.83 RARB (0.68) RARBRARARARGRAB9ASMN1; SMN2
SCHEMBL15717036 0.83 RXRA (0.53) RARBRARARARGRAB9ASMN1; SMN2
SCHEMBL10052771 0.82 MCL1 (0.61) RARBRARARARGSMN1; SMN2MCL1
SCHEMBL31725051 0.82 ACMSD (0.63) RARBRARARARGMCL1KDM4E
SCHEMBL4652842 0.82 RARB (0.58) RARBRARARARGMCL1ALDH1A1
SCHEMBL121429 0.82 ACMSD (0.63) RARBRARARARGMCL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019056120-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF DALRIADA THERAPEUTICS INC. (CA) 2019-03-28 WO disclosed